BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 16, 2004
View Archived Issues
Gilead Seeking Approval For New Combination AIDS Pill
Gilead Sciences Inc. is requesting FDA approval of a co-formulation combining Viread with Emtriva in a single pill dosed once daily to be taken with other antiretrovirals for the treatment of HIV. (BioWorld Today)
Read More
CoTherix IPO Seeking $70M To Fund Hypertension Drug
Read More
ChemoCentryx, Forest Form Partnership On Chemokines
Read More
CancerVax In-Licenses T-Oligos Platform To Oncology Pipeline
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More